Published in J Immunol on July 01, 1965
Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol Rev (1983) 5.73
Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera. J Clin Invest (1976) 5.54
Inactivation of the bactericidal activity of human serum by liquoid (sodium polyanetholsulfonate). Appl Microbiol (1969) 5.30
Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin Diagn Lab Immunol (1997) 4.65
A kinetic study of the bacteriolytic and bactericidal action of human serum. Immunology (1967) 3.40
The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94
In vitro interaction of Bacteroides fragilis with polymorphonuclear leukocytes and serum factors. Infect Immun (1975) 1.67
Effects of serum components on gram-negative bacteria during bactericidal reactions. Infect Immun (1971) 1.39
Bactericidal properties of human cell-free lymph. Infect Immun (1976) 1.27
Analysis of outer membrane components of Escherichia coli ML308 225 and of a serum-resistant mutant. Infect Immun (1980) 1.26
Serum sensitivity of a Pseudomonas aeruginosa mucoid strain. Infect Immun (1984) 1.21
Deficiency of serum bactericidal activity against Salmonella typhimurium in sickle cell anaemia. Clin Exp Immunol (1977) 1.02
Survival of bacteria in carcasses. Appl Environ Microbiol (1979) 0.95
Bactericidal action of fresh rabbit blood against Brucella abortus. J Bacteriol (1968) 0.95
Relationship between bactericidal action of complement and fluidity of cellular membranes. Infect Immun (1978) 0.91
Characterization of a Campylobacter jejuni VirK protein homolog as a novel virulence determinant. Infect Immun (2009) 0.82
Pyelonephritis XI. Effect of Growth Phase of Streptococcus faecalis on Serum Susceptibility and Virulence. Infect Immun (1970) 0.81
Resistance of Escherichia coli to osmotically introduced complement component C9. Infect Immun (1991) 0.80
Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement. Infect Immun (2015) 0.79
Serum bactericidal resistance of faecal Escherichia coli and bactericidal competence of serum from patients with ulcerative colitis. J Clin Pathol (1990) 0.78
Rapid killing of Capnocytophaga canimorsus and Capnocytophaga cynodegmi by human whole blood and serum is mediated via the complement system. Springerplus (2015) 0.78
Humoral and cellular responses to gram-negative infections. Proc R Soc Med (1969) 0.75
Influence of antibodies to mannophosphoinositides on phospholipid synthesis in Mycobacterium smegmatis ATCC 607. Infect Immun (1982) 0.75
Dermatomyositis; report of 26 cases in children with a discussion of endocrine therapy in 13. Pediatrics (1953) 1.84
ANTIBIOTIC PROPHYLAXIS IN ACUTE VIRAL RESPIRATORY DISEASES. Am J Dis Child (1965) 1.74
NEONATAL LISTERIOSIS. SIX CASE REPORTS AND A REVIEW OF THE LITERATURE. Pediatrics (1964) 1.59
Measurement of the components of complement by the reagent titration technique. Z Immun exp ther (1960) 1.55
Anaphylactoid purpura (Schönlein-Henoch syndrome); a long-term follow-up study with special reference to renal involvement. Pediatrics (1955) 1.42
Mycobacterial cervical adenitis in children. J Pediatr (1961) 1.24
The properdin system and immunity. VI. The inactivation of Newcastle disease virus by the properdin system. J Exp Med (1956) 1.16
Duplication of the terminal ileum; report of a case operated upon successfully on the fifth day of life. Ann Surg (1952) 1.10
The properdin system and immunity. X. Characterization of partially purified human properdin. J Immunol (1959) 1.06
The effects of serum complement and its components on the rheumatoid latex fixation test. Arthritis Rheum (1958) 1.03
Concerning the nature of the properdin system. Pediatrics (1958) 0.97
The properdin system and immunity. XIV. The injection of human properdin into rabbits and the production of antibodies to properdin. J Immunol (1960) 0.93
Properdin and the inactivation of viruses. Ann N Y Acad Sci (1960) 0.90
CONVULSIVE EQUIVALENT SYNDROME OF CHILDHOOD. J Pediatr (1964) 0.88
Systemic lupus erythematosus. Description of 37 cases in children and a discussion of endocrine therapy in 32 of the cases. Pediatrics (1960) 0.86
STAPHYLOCOCCAL PNEUMONIA IN CHILDHOOD; LONG-TERM FOLLOW-UP. Am J Dis Child (1964) 0.85
INCONSTANCY OF THE LEAN BODY MASS. Ann N Y Acad Sci (1963) 0.84
Relationship of body composition to basal metabolic rate in normal man. J Appl Physiol (1953) 0.79
FEMORAL ARTERIOVENOUS FISTULA FOLLOWING VENIPUNCTURE. Pediatrics (1965) 0.79
The nature and interactions of the properdin system. Acta Haematol (1959) 0.76
A case of horseshoe kidney presenting as an intestinal obstruction. J Med Assoc State Ala (1956) 0.75
Immunity, infection, and properdin. Arch Intern Med (1959) 0.75
The properdin system and immunity. XV. Some biologic effects of the administration of zvmosan and other polvsaccharides to rabbits, and the presence of antibodies to zymosan in human and rabbit serum. J Lab Clin Med (1961) 0.75
Touching a cure of an inveterate phrensy by the transfusion of blood. N Engl J Med (1953) 0.75
Acute rheumatic fever. Arthritis Rheum (1961) 0.75
HOW IMPORTANT ARE MACROGLOBULIN ANTIBODIES TO THE NEWBORN INFANT? Pediatrics (1964) 0.75